June 17, 2020 / 3:54 PM / a month ago

BRIEF-Median Technologies Announces Positive Preliminary Results About Ibiopsy® Clinical Development Plan

June 17 (Reuters) - MEDIAN TECHNOLOGIES SA:

* ENCOURAGING PRELIMINARY RESULTS ABOUT THE IBIOPSY® CLINICAL DEVELOPMENT PLAN ON LIVER CANCER AND THE TECHNOLOGICAL METHODS THEREIN

* DEVELOPMENT OF A FIBROSIS BIOMARKER FROM CT SCAN IMAGING

* A BETTER PERFORMING BIOMARKER COMPARED TO EXISTING IMAGING BIOMARKERS

* IBIOPSY® DEVELOPMENT PROGRAM SUPPORTED BY EUROPEAN INVESTMENT BANK (EIB) THROUGH FINANCIAL LOAN OF EUR 35 MILLION UNDER JUNCKER PLAN, EUROPEAN FUND FOR STRATEGIC INVESTMENTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below